H. Tsuda

T. Kohno, H. Asamura, H. Tsuda, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast

S. Hirohashi, H. Tsuda, T. Fukutomi, 1994, Japanese journal of cancer research : Gann.

Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.

Y. Nakamura, S. Hirohashi, H. Tsuda, 1994, Cancer research.

Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study

H. Tsuda, J. Yamamoto, S. Ueda, 2011, Breast cancer.

Early Reduction in Standardized Uptake Value After One Cycle of Neoadjuvant Chemotherapy Measured by Sequential FDG PET/CT is an Independent Predictor of Pathological Response of Primary Breast Cancer

H. Tsuda, J. Yamamoto, S. Ueda, 2010, The breast journal.

Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer

Takayuki Kobayashi, Hidetaka Mochizuki, Hitoshi Tsuda, 2008, BMC Cancer.

Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas

T. Kohno, T. Shibata, H. Asamura, 2011, The American journal of surgical pathology.

Inflammatory myofibroblastic tumour of the lung with a novel PPFIBP1–ALK fusion variant

T. Shibata, Shun‐ichi Watanabe, H. Tsuda, 2013, Histopathology.

Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays

H. Ueno, P. Caie, H. Tsuda, 2020, Virchows Archiv.

Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers

T. Ochiya, M. Ono, A. Shimomura, 2020, Molecular oncology.

Analysis of sentinel node involvement in gastric cancer.

J. Inazawa, S. Kosuda, H. Tsuda, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue.

J. Inazawa, H. Tsuda, I. Imoto, 2008, International journal of oral and maxillofacial surgery.

Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas.

J. Inazawa, H. Tsuda, I. Imoto, 2005, Cancer letters.

Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging.

H. Tsuda, M. Takano, J. Hirata, 2008, Oncology reports.

Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas

H. Tsuda, M. Takano, J. Hirata, 2018, Oncology.

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients

H. Ueno, H. Tsuda, Y. Hirose, 2021, Biomarker research.

Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.

H. Tsuda, T. Kondo, A. Kawai, 2013, Journal of proteomics.

Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression.

S. Hirohashi, T. Oda, H. Tsuda, 1994, Cancer letters.

Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.

T. Kasamatsu, K. Shiromizu, H. Tsuda, 2002, Gynecologic oncology.

Frequent loss of heterozygosity at the DCC locus in gastric cancer.

S. Hirohashi, J. Yokota, M. Noguchi, 1992, Cancer research.

The expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer

A. Shiotani, H. Tsuda, I. Imoto, 2014, Human Cell.

Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer

H. Tsuda, F. Akiyama, S. Masuda, 2020, Breast Cancer.

Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome

C. Shimizu, H. Tsuda, K. Aogi, 2012, Oncology.

Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.

H. Tsuda, F. Akiyama, M. Kurosumi, 2007, International journal of oncology.

Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.

K. Yonemori, T. Kinoshita, Y. Fujiwara, 2013, Molecular and clinical oncology.

8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method.

S. Hirohashi, J. Yokota, H. Tsuda, 1995, Cancer letters.

Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics

T. Shibata, H. Tsuda, M. Fukayama, 2010, Modern Pathology.

Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand

S. Hirohashi, H. Tsuda, T. Sugimura, 1993, Molecular carcinogenesis.

Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women

C. Shimizu, Y. Fujiwara, H. Tsuda, 2013, Breast Cancer Research and Treatment.

Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer.

A. Shiotani, Tesshi Yamada, T. Matsunobu, 2014, Anticancer research.

carcinomas with myoepithelial differentiation receptor (EGFR) in mammary high grade ductal Frequent overexpression of epidermal growth factor

T. Kinoshita, H. Tsuda, T. Tashiro, 2008 .

Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation

H. Tsuda, T. Tashiro, S. Akashi-Tanaka, 2005, Journal of Clinical Pathology.

DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers

H. Tsuda, T. Goto, M. Takano, 2015, Journal of gynecologic oncology.

Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients

K. Horie-Inoue, S. Inoue, C. Shimizu, 2012, Hormones and Cancer.

Pathogenetic significance of p53 and c‐Ki‐ras gene mutations and human papillomavirus dna integration in adenocarcinoma of the uterine cervix and uterine isthmus

S. Hirohashi, H. Tsuda, K. Jiko, 1994, International journal of cancer.

Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes

S. Hirohashi, H. Tsuda, 1992, Japanese journal of cancer research : Gann.

An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway

H. Tsuda, M. Takano, O. Matsubara, 2009, Virchows Archiv.

Aberrant expression of p27Kip1-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways

H. Tsuda, M. Takano, O. Matsubara, 2009, Virchows Archiv.

Optimizing microvessel counts according to tumor zone in invasive ductal carcinoma of the breast.

H. Tsuda, T. Hasebe, Y. Tsubono, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Analysis of Ki‐67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer

H. Iwata, T. Kinoshita, H. Tsuda, 2013, Cancer.

Clinical and Histopathological Characteristics of Patients with a Positive Breast Cancer Family History

H. Tsuda, T. Fukutomi, Hiroshi Yamamoto, 2004 .

Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients

H. Tsuda, I. Miyashiro, H. Katai, 2013, Gastric Cancer.

Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examination.

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2013, Breast.

Molecular Detection of Lymph Node Metastases in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay

H. Tsuda, F. Akiyama, K. Wakasa, 2009, Clinical Cancer Research.

Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions

T. Kinoshita, H. Tsuda, S. Akashi-Tanaka, 2012, Virchows Archiv.

Well-differentiated Liposarcoma With Low-grade Osteosarcomatous Component: An Underrecognized Variant

T. Shibata, H. Tsuda, M. Fukayama, 2010, The American journal of surgical pathology.

Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry

H. Miyata, T. Kinoshita, H. Tsuda, 2019, Annals of surgical oncology.

SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells*

J. Inazawa, K. Miyazono, M. Matsuoka, 2009, Journal of Biological Chemistry.

Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice.

J. Yokota, H. Tsuda, Y. Niitsu, 1998, Cancer letters.

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

H. Tsuda, K. Nishio, Y. Kodera, 2011, Breast Cancer Research.

Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.

H. Tsuda, K. Nakanishi, K. Ito, 2019, Human pathology.

Clinicopathologic Analysis of Multiple (Five or More) Atypical Adenomatous Hyperplasias (AAHs) of the Lung: Evidence for the AAH-Adenocarcinoma Sequence

H. Asamura, H. Tsuda, K. Tsuta, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

H. Tsuda, M. Takano, M. Miyamoto, 2022, Diagnostic Pathology.

Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, American journal of cancer research.

Immunophenotype and Human Papillomavirus Status of Serous Adenocarcinoma of the Uterine Cervix

T. Kasamatsu, H. Tsuda, S. Okada, 2015, Pathology & Oncology Research.

Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

S. Hirohashi, T. Oda, A. Scarpa, 1992, Cancer research.

Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.

H. Tsuda, D. Morita, T. Ichikura, 2005, Japanese journal of clinical oncology.

Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival

H. Tsuda, K. Ito, Kimiya Sato, 2021, Virchows Archiv.

In vivo evaluation of a modified linear stapling device designed to facilitate accurate pathologic examination of the surgical margin

H. Tsuda, J. Yamamoto, H. Tsujimoto, 2016, Gastric Cancer.

Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma

J. Inazawa, H. Tsuda, I. Imoto, 2008, Cancer science.

Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

J. Inazawa, K. Tanaka, T. Kawano, 2007, Oncogene.

Correlation of DNA hypomethylation at pericentromeric heterochromatin regions of chromosomes 16 and 1 with histological features and chromosomal abnormalities of human breast carcinomas.

S. Hirohashi, H. Tsuda, Y. Kanai, 2002, The American journal of pathology.

SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.

H. Tsuda, Y. Kanai, E. Otsuji, 2016, Human pathology.

Clinical use of contrast-enhanced computed tomography for decision making in breast conserving surgery

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1997, Breast cancer.

Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.

S. Hirohashi, H. Tsuda, T. Fukutomi, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognosis of a series of 763 consecutive node‐negative invasive breast cancer patients without adjuvant therapy: Analysis of clinicopathological prognostic factor

H. Tsuda, K. Miyamoto, S. Akashi-Tanaka, 1999, Journal of surgical oncology.

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.

H. Tsuda, Tsuyoshi Saito, M. Hatae, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

H. Tsuda, H. Yoshikawa, T. Kaku, 2001, Cancer letters.

Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

A. Shimomura, H. Tsuda, F. Akiyama, 2022, Breast Cancer.

The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas

H. Tsuda, M. Takano, M. Miyamoto, 2022, Archives of Gynecology and Obstetrics.

Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator

H. Asamura, H. Tsuda, K. Tsuta, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours.

A. Gemma, H. Asamura, H. Tsuda, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

H. Tsuda, N. Shinomiya, I. Nagaoka, 2015, British Journal of Cancer.

ACTN4 gene amplification and actinin‐4 protein overexpression drive tumour development and histological progression in a high‐grade subset of ovarian clear‐cell adenocarcinomas

Tesshi Yamada, J. Inazawa, H. Tsuda, 2012, Histopathology.

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG

H. Iwata, H. Tsuda, F. Akiyama, 2014, Breast Cancer.

p53 Gene Mutation Spectrum in Hepatocellular Carcinoma1

S. Hirohashi, A. Scarpa, H. Tsuda, 2006 .

Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer

H. Tsuda, D. Morita, O. Matsubara, 2006, Modern Pathology.

Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas

H. Asamura, H. Tsuda, K. Tsuta, 2013, Applied immunohistochemistry & molecular morphology : AIMM.

Preferential Occurrence of Breast Carcinomas with Loss of Chromosome 16q and der(16)t(1;16)/der(1;16) in Middle‐aged Patients with Hyperplasia of Mammary Glands

S. Hirohashi, H. Tsuda, T. Fukutomi, 2000, Japanese journal of cancer research : Gann.

Pulmonary neuroendocrine tumors with nuclear inclusion.

H. Asamura, H. Tsuda, K. Tsuta, 2013, Pathology, research and practice.

Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma

J. Inazawa, H. Tsuda, O. Matsubara, 2007, Virchows Archiv.

Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: Potential role in tumor progression

H. Tsuda, T. Asano, O. Matsubara, 2010, Cancer science.

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.

T. Shibata, H. Tsuda, M. Fukayama, 2011, Lung cancer.

Expression of KIT, EGFR, HER‐2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: Implication for a new therapeutic approach

H. Tsuda, O. Matsubara, S. Kitahara, 2005, Pathology international.

Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated‐type breast carcinomas with ‘stem‐cell‐like’ features

S. Hirohashi, H. Tsuda, T. Hasegawa, 2005, Cancer science.

Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.

H. Tsuda, M. Sakamoto, T. Goto, 2006, Oncology reports.

Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.

J. Inazawa, H. Tsuda, I. Imoto, 2009, Carcinogenesis.

Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells

J. Inazawa, Y. Mizutani, T. Miki, 2007, Cancer science.

Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis

S. Hirohashi, J. Inazawa, H. Tsuda, 2006, Oncogene.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Oncotarget.

Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, Anticancer research.

Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma.

H. Asamura, H. Tsuda, K. Tsuta, 2013, Japanese journal of clinical oncology.

Clear Cell Adenocarcinoma With a Component of Poorly Differentiated Histology: A Poor Prognostic Subgroup of Ovarian Clear Cell Adenocarcinoma

H. Tsuda, J. Kigawa, H. Kurachi, 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Synchronous unilateral triple breast cancers composed of invasive ductal carcinoma, invasive lobular carcinoma, and Paget’s disease

T. Kinoshita, H. Tsuda, T. Hasebe, 2014, Breast Cancer.

Clear‐cell adenofibroma can be a clonal precursor for clear‐cell adenocarcinoma of the ovary: a possible alternative ovarian clear‐cell carcinogenic pathway

H. Tsuda, M. Takano, O. Matsubara, 2008, The Journal of pathology.

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

H. Tsuda, N. Shinomiya, I. Nagaoka, 2016, British Journal of Cancer.

Esophageal pleomorphic giant cell carcinoma combined with small cell carcinoma

H. Tsuda, O. Matsubara, S. Tamai, 2007, Pathology international.

Treatment of noninvasive carcinoma: Fifteen-Year results at the National Cancer Center Hospital in Tokyo

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2000, Breast cancer.

Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic review

H. Tsuda, T. Goto, M. Takano, 2013, Journal of gynecologic oncology.

High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy

S. Hirohashi, H. Tsuda, T. Kihana, 1992, Japanese journal of cancer research : Gann.

The prognostic value of tumor-associated carbohydrate structures correlated with gene amplifications in human breast carcinomas

S. Hirohashi, H. Tsuda, Y. Shimosato, 1991, The Japanese journal of surgery.

Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.

A. Gemma, T. Shibata, H. Asamura, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

H. Tsuda, M. Takano, M. Miyamoto, 2021, Medicine.

Expression of L-Type Amino Acid Transporter 1 is a Predictive Biomarker of Intravesical Recurrence in Patients with Non-Muscle Invasive Bladder Cancer

H. Tsuda, H. Sakurai, H. Sawazaki, 2021, Research and reports in urology.

Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages

H. Tsuda, M. Takano, M. Miyamoto, 2021, BMC Cancer.

Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with a BRCA1 germline mutation.

H. Tsuda, T. Ushijima, S. Akashi-Tanaka, 2000, Japanese journal of clinical oncology.

The first Japanese nationwide multicenter study of BRCA mutation testing in ovarian cancer: CHARacterizing the cross-sectionaL approach to Ovarian cancer geneTic TEsting of BRCA (CHARLOTTE)

H. Tsuda, K. Yoshihara, T. Enomoto, 2019, International Journal of Gynecological Cancer.

Allelic loss at chromosome band 8p21.3‐p22 is associated with progression of hepatocellular carcinoma

Y. Nakamura, S. Hirohashi, M. Emi, 1993, Genes, chromosomes & cancer.

A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?

H. Tsuda, T. Hasebe, M. Komura, 2020, Breast Cancer.

Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer

H. Tsuda, E. Otsuji, A. Shiozaki, 2022, Cancer science.

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients

H. Ueno, H. Tsuda, Kazuki Kobayashi, 2021, Biomarker research.

p53 gene mutation spectrum in hepatocellular carcinoma.

S. Hirohashi, T. Oda, A. Scarpa, 1992, Cancer research.

Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis.

Yukiko Nakamura, H. Tsuda, T. Kondo, 2011, Journal of proteomics.

Interlaboratory Comparison in HercepTest Assessment of HER2 Protein Status in Invasive Breast Carcinoma Fixed With Various Formalin-based Fixatives

H. Tsuda, Toshihiko Kato, Tomoyuki Kato, 2003, Applied immunohistochemistry & molecular morphology : AIMM.

Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.

Yukiko Nakamura, H. Tsuda, T. Kondo, 2012, Journal of proteomics.

Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma

H. Tsuda, M. Ikegami, H. Taniguchi, 2013, Pathology international.

Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum

H. Tsuda, Y. Kanai, H. Taniguchi, 2013, The Journal of pathology.

High amplification of the hst‐1 gene correlates with haematogenous recurrence after curative resection of oesophageal carcinoma

S. Hirohashi, H. Tsuda, M. Kobayashi, 1995, The British journal of surgery.

Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.

S. Hirohashi, H. Tsuda, 1995, Cancer research.

SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis

H. Okano, Tesshi Yamada, H. Tsuda, 2013, Modern Pathology.

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

C. Desmedt, D. Larsimont, P. V. van Diest, 2022, Modern Pathology.

The Possible Prognostic Significance of p53 Immunostaining Status of the Primary Tumor in Patients Developing Local Recurrence after Breast-Conserving Surgery

H. Tsuda, F. Akiyama, S. Noguchi, 1998, Oncology.

Deletion mapping of chromosome 3p in human uterine cervical cancer.

M. Oshimura, S. Hirohashi, T. Kohno, 1993, Oncogene.

Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

H. Tsuda, K. Wakazono, T. Sugimura, 2002, Japanese journal of clinical oncology.

Cumulative alterations of p27Kip1‐related cell‐cycle regulators in the development of endometriosis‐associated ovarian clear cell adenocarcinoma

H. Tsuda, M. Takano, O. Matsubara, 2010, Histopathology.

Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case series

H. Shinmoto, Y. Ueno, T. Tamada, 2022, Abdominal Radiology.

Reply to “Survival analysis in a prediction model for early systemic recurrence in breast cancer”

H. Tsuda, S. Noguchi, T. Osako, 2022, Cancer.

NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review.

H. Tsuda, K. Tsuta, T. Igari, 2015, Pathology, research and practice.

Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.

S. Hirohashi, U. Thorgeirsson, H. Tsuda, 1997, Human pathology.

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers

H. Tsuda, I. Nagaoka, T. Goto, 2017, Cancer Chemotherapy and Pharmacology.

Natural state of mutant p53 protein and heat shock protein 70 in breast cancer tissues.

S. Hirohashi, H. Tsuda, M. Suzuki, 1995, Laboratory investigation; a journal of technical methods and pathology.

Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004–2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society

H. Miyata, Masayuki Yoshida, T. Kinoshita, 2019, Breast Cancer.

Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors

H. Tsuda, T. Asano, O. Matsubara, 2014, Virchows Archiv.

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma

S. Hirohashi, J. Yokota, H. Tsuda, 1990, Japanese journal of cancer research : Gann.

Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern.

M. Makuuchi, S. Hirohashi, H. Tsuda, 1989, The American journal of surgical pathology.

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma

S. Hirohashi, Teruhiko Yoshida, H. Tsuda, 1989, Japanese journal of cancer research : Gann.

Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.

M. Makuuchi, H. Hasegawa, S. Hirohashi, 1988, Cancer research.

Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis

Mitsuaki Suzuki, H. Tsuda, J. Kigawa, 2007, International Journal of Clinical Oncology.

Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.

Mitsuaki Suzuki, H. Tsuda, J. Kigawa, 2006, Oncology reports.

Diagnostic efficacy of ascites cell block for ovarian clear cell carcinoma

H. Tsuda, M. Takano, M. Miyamoto, 2021, Diagnostic cytopathology.

Different expression patterns of KIT, EGFR, and HER‐2 (c‐erbB‐2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma

T. Kasamatsu, H. Tsuda, O. Matsubara, 2003, Cancer science.

Allelotyping analysis suggesting a consecutive progression from intratubular germ cell neoplasia to seminoma and then to embryonal carcinoma of the adult testis.

H. Tsuda, T. Asano, O. Matsubara, 2013, Human pathology.

Less Impact of Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary: A Retrospective Japan Clear Cell Carcinoma Study

Mitsuaki Suzuki, H. Tsuda, J. Kigawa, 2010, International Journal of Gynecologic Cancer.

Prognostic Value of the Number and Size of Venous Invasions in pT3 Colorectal Cancer: A Prospective Observational Study

H. Ueno, H. Tsuda, J. Yamamoto, 2014, World Journal of Surgery.

Immunoreaction at 43 kDa with Anti‐ubiquitin Antibody in Breast Neoplasms

S. Hirohashi, H. Tsuda, Y. Matsuno, 1997, Japanese journal of cancer research : Gann.

Therapeutic effect of edaravone on inner ear barotrauma in the guinea pig

A. Shiotani, T. Matsunobu, H. Tsuda, 2009, Neurochemistry International.

Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.

H. Tsuda, K. Tobinai, D. Maruyama, 2013, Human pathology.

Steroid receptor expression in thymomas and thymic carcinomas

M. Okada, H. Asamura, H. Tsuda, 2011, Cancer.

Follicular lymphoma with marked monocytoid or plasmacytoid differentiation and tiny or indistinct follicles: a case study of four patients

Y. Kawabata, H. Tsuda, K. Tobinai, 2011, Leukemia & lymphoma.

Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma

H. Tsuda, K Ito, S. Matsukuma, 2022, BMC cancer.

Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia.

H. Tsuda, T. Goto, M. Takano, 2006, Oncology reports.

Galectin-9 Enhances Cytokine Secretion, but Suppresses Survival and Degranulation, in Human Mast Cell Line

T. Niki, H. Tsuda, S. Nakae, 2014, PloS one.

Bilateral malignant lymphoma of the breast in patients with a familial history of cancer: A report of three cases

H. Tsuda, T. Fukutomi, Hiroshi Yamamoto, 2005, Surgery Today.

MDM2 and CDK4 Immunohistochemical Coexpression in High-grade Osteosarcoma: Correlation With a Dedifferentiated Subtype

T. Shibata, H. Tsuda, M. Fukayama, 2012, The American journal of surgical pathology.

Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG

H. Iwata, H. Tsuda, F. Akiyama, 2015, Breast Cancer.

Effect of HER‐2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma

H. Tsuda, T. Kita, K. Furuya, 2007, The journal of obstetrics and gynaecology research.

RETRACTED: Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: A pilot study

H. Tsuda, Tsuyoshi Saito, M. Uematsu, 2006 .

Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: a pilot study.

H. Tsuda, Tsuyoshi Saito, M. Uematsu, 2006, Surgery.

The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas

H. Tsuda, M. Takano, M. Miyamoto, 2022, Archives of Gynecology and Obstetrics.

Histological Grading of Ovarian Clear Cell Adenocarcinoma: Proposal for a Simple and Reproducible Grouping System Based on Tumor Growth Architecture

H. Tsuda, J. Kigawa, M. Takano, 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.

S. Hirohashi, H. Tsuda, M. Sasako, 1993, Cancer.

Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2015, Pathology international.

Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer

H. Tsuda, D. Morita, M. Kinoshita, 2008, Journal of surgical oncology.

Evaluation of tumor-infiltrating lymphocytes (TIL) and tumor cell apoptosis as predictive markers for response to neoadjuvant chemotherapy in triple-negative breast cancer.

T. Shibata, M. Ono, C. Shimizu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Contrast‐enhanced computed tomography detection of occult breast cancers presenting as axillary masses

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1999, Breast Cancer Research and Treatment.

Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review

M. Yunokawa, K. Yonemori, C. Shimizu, 2012, Case Reports in Oncology.

Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.

H. Tsuda, H. Hano, M. Ikegami, 2011, Human pathology.

Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?

H. Tsuda, I. Nagaoka, T. Goto, 2017, Cancer Chemotherapy and Pharmacology.

Clinicopathologic and Technical Factors Associated with the Uptake of Radiocolloid by Sentinel Nodes in Patients with Breast Cancer

S. Kosuda, H. Tsuda, S. Kusano, 2003, Surgery Today.

Diagnostic value of enhanced computed tomography in the detection of the widely spreading intraductal component of breast cancer: Case reports

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1997, Breast cancer.

Sentinel lymph node biopsy using indigo carmine blue dye and the validity of '10% rule' and '4 nodes rule'.

T. Kinoshita, H. Tsuda, T. Hojo, 2012, Breast.

Determination of c‐erbB‐2 Protein in Primary Breast Cancer Tissue Extract Using an Enzyme Immunoassay

H. Tsuda, T. Fukutomi, Toru Watanabe, 1993, Japanese journal of cancer research : Gann.

BRCA1 andBRCA2 germline mutations in Japanese with hereditary breast cancer families

H. Tsuda, T. Ushijima, T. Fukutomi, 1997 .

Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.

Y. Iwasaki, H. Tsuda, S. Akashi-Tanaka, 1998, Japanese journal of clinical oncology.

Japanese late-onset breast cancer families: Their clinicopathological characteristics and absence ofBRCA1 andBRCA2 germline mutations

H. Tsuda, T. Ushijima, Y. Kanai, 1998, Breast cancer.

Clear Cell Adenocarcinoma Associated With Clear Cell Adenofibromatous Components: A Subgroup of Ovarian Clear Cell Adenocarcinoma With Distinct Clinicopathologic Characteristics

H. Tsuda, O. Matsubara, T. Kita, 2007, The American journal of surgical pathology.

Follow-up Data of 10 Patients With B-cell Non-Hodgkin Lymphoma With a CD20-negative Phenotypic Change After Rituximab-containing Therapy

H. Tsuda, K. Tobinai, D. Maruyama, 2013, The American journal of surgical pathology.

Chronic lymphocytic leukemia and concurrent seminoma in the same testis

H. Tsuda, Kimiya Sato, Kosuke Miyai, 2021, Journal of pathology and translational medicine.

Mucinous breast carcinoma with a lobular neoplasia component: A subset with aberrant expression of cell adhesion and polarity molecules and lack of neuroendocrine differentiation

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2014, Pathology international.

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases.

S. Hirohashi, H. Tsuda, T. Fukutomi, 2000, The American journal of surgical pathology.

Invasive Ductal Carcinoma of the Breast with a Large Central Acellular Zone Associated with Matrix-producing Carcinoma

H. Tsuda, S. Kusano, H. Mochizuki, 2004, Tumori.

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas

H. Tsuda, M. Takano, K. Furuya, 2017, Journal of gynecologic oncology.

Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix.

T. Kasamatsu, H. Tsuda, T. Onda, 2009, Gynecologic oncology.

Association of point mutation in c‐Ki‐ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes

S. Hirohashi, H. Tsuda, Y. Shimosato, 1990, Cancer.

A case of dermatofibrosarcoma protuberans in the skin over the breast

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1997, Breast cancer.

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

H. Tsuda, S. Ueda, H. Mochizuki, 2008, Japanese journal of clinical oncology.

Clinically useful detection criteria for sentinel nodes in patients with breast cancer using a radioisotope technique.

S. Kosuda, H. Tsuda, S. Kusano, 2002, Japanese journal of clinical oncology.

Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q

H. Tsuda, T. Fukutomi, S. Nakano, 2010, Breast cancer.

Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis

G. Ball, E. Rakha, C. Quinn, 2022, Breast Cancer Research and Treatment.

Different pattern of loss of heterozygosity among endocervical‐type adenocarcinoma, endometrioid‐type adenocarcinoma and adenoma malignum of the uterine cervix

S. Hirohashi, T. Kasamatsu, H. Tsuda, 2002, International journal of cancer.

Bilateral breast cancer in a patient with a strong family history of cancer: Analysis of p53 germ line mutations

H. Tsuda, T. Ushijima, T. Fukutomi, 1994, Breast cancer.

Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma.

H. Tsuda, M. Takano, K. Furuya, 2018, Anticancer research.

Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis

J. Inazawa, H. Tsuda, S. Okabe, 2005, Laboratory Investigation.

Metachronous bilateral triple-negative breast cancer associated with neurofibromatosis type 1: A case report

H. Ueno, H. Tsuda, J. Yamamoto, 2019, Oncology letters.

Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

H. Tsuda, M. Takano, J. Hirata, 2019, Oncology.

Immunohistochemical study of c‐erbB‐2 oncoprotein overexpression in human major salivary gland carcinoma: An indicator of aggressiveness

S. Hirohashi, H. Tsuda, Y. Shimosato, 1992, The Laryngoscope.

Detection of allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens.

S. Hirohashi, H. Tsuda, K. Shimamura, 1996, Acta cytologica.

Malignant progression of adenomyoepithelial adenosis of the breast

S. Hirohashi, H. Tsuda, T. Fukutomi, 1994, Pathology international.

A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).

H. Tsuda, T. Baba, K. Ushijima, 2015, Japanese journal of clinical oncology.

A non-randomized con fi rmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer : Japan Clinical Oncology Group Study ( JCOG 1203 )

H. Tsuda, T. Baba, K. Ushijima, 2015 .

Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer

H. Tsuda, H. Mochizuki, T. Einama, 2006, International Journal of Clinical Oncology.

The Impact of Complete Surgical Staging Upon Survival in Early-Stage Ovarian Clear Cell Carcinoma: A Multi-institutional Retrospective Study

Mitsuaki Suzuki, H. Tsuda, J. Kigawa, 2009, International Journal of Gynecologic Cancer.

Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types

S. Hirohashi, Y. Taketani, H. Tsuda, 2002, Japanese journal of cancer research : Gann.

Local recurrence after conservative surgery without postoperative radiation for pure tubular carcinoma of the breast: A case report with reference to multifocality of tubular carcinoma

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1998, Breast cancer.

Detection of numerical alterations of chromosome 1 in cytopathological specimens of breast tumors by chromogen in situ hybridization

S. Hirohashi, H. Tsuda, T. Fukutomi, 2001, Pathology international.

Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin‐like growth factor receptor type 1

H. Tsuda, O. Matsubara, S. Ueda, 2006, Cancer science.

c‐erbB‐2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

C. Shimizu, H. Tsuda, S. Akashi-Tanaka, 2000, Journal of surgical oncology.

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

H. Tsuda, M. Kurosumi, T. Ohta, 2010, Breast cancer.

Eyelid metastasis from breast cancer showing marked response to chemotherapy.

H. Tsuda, M. Narabayashi, A. Kaneko, 1995, Japanese journal of clinical oncology.

Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.

S. Hirohashi, J. Inazawa, T. Kasamatsu, 2008, Cancer research.

YAP is a candidate oncogene for esophageal squamous cell carcinoma.

J. Inazawa, T. Kawano, H. Tsuda, 2011, Carcinogenesis.

New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus

H. Tsuda, A. Ochiai, T. Hasebe, 2000, Pathology international.

The expression and clinical significance of ribophorin II (RPN2) in human breast cancer

T. Ochiya, M. Ono, T. Kinoshita, 2015, Pathology international.

Screening of DNA copy‐number aberrations in gastric cancer cell lines by array‐based comparative genomic hybridization

Hidetaka Mochizuki, Hitoshi Tsuda, J. Inazawa, 2005, Cancer science.

Evaluation of the Interobserver Agreement in the Number of Mitotic Figures Breast Carcinoma as Simulation of Quality Monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS‐BC) Protocol

Tadashi Hasegawa, Katsushige Yamashiro, Hitoshi Tsuda, 2000, Japanese journal of cancer research : Gann.

High-grade Lung Adenocarcinoma With Fetal Lung–like Morphology: Clinicopathologic, Immunohistochemical, and Molecular Analyses of 17 Cases

H. Asamura, D. Takai, H. Tsuda, 2013, The American journal of surgical pathology.

Point Mutation of c‐Ki‐ras Oncogene in Gastric Adenoma and Adenocarcinoma with Tubular Differentiation

S. Hirohashi, H. Tsuda, Y. Shimosato, 1991, Japanese journal of cancer research : Gann.

Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression

H. Tsuda, K. Nakanishi, K. Ito, 2019, Virchows Archiv.

Primary carcinoid tumor of the testis: Immunohistochemical, ultrastructural and FISH analysis with review of the literature

H. Tsuda, T. Motoyama, T. Ishihara, 2003, Pathology international.

Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors

H. Tsuda, K. Ito, S. Matsukuma, 2021, Virchows Archiv.

Frequent EGFR expression/EGFR amplification and lack of activating mutation in testicular choriocarcinoma

H. Tsuda, K. Ito, S. Matsukuma, 2020, Pathology international.

Altered expression of p27Kip1‐interacting cell‐cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression

H. Tsuda, T. Asano, O. Matsubara, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Neuroendocrine Carcinoma of the Stomach: Morphologic and Immunohistochemical Characteristics and Prognosis

H. Tsuda, H. Katai, S. Morita, 2013, The American journal of surgical pathology.

Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer

S. Hirohashi, H. Tsuda, Setsuo Hirohashi, 1994, International journal of cancer.

DNA hypermethylation at the D17S5 locus and reduced HIC‐1mRNA expression are associated with hepatocarcinogenesis

S. Hirohashi, H. Tsuda, Y. Kanai, 1999, Hepatology.

The E‐cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas

S. Hirohashi, H. Tsuda, A. Ochiai, 1997, International journal of cancer.

Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis

S. Hirohashi, H. Tsuda, T. Sugimura, 1996, Japanese journal of cancer research : Gann.

Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients

S. Hirohashi, H. Tsuda, T. Sugimura, 1990, Japanese journal of cancer research : Gann.

Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

S. Hirohashi, J. Yokota, H. Tsuda, 1989, Cancer research.

Sialyl Lewisx expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer

H. Ueno, H. Tsuda, J. Yamamoto, 2017, Oncology letters.

Fibrotic focus in infiltrating ductal carcinoma of the breast: A significant histopathological prognostic parameter for predicting the long-term survival of the patients

S. Hirohashi, H. Tsuda, Y. Shimosato, 1998, Breast Cancer Research and Treatment.

Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Histopathological Prognostic Parameter for Tumor Recurrence and Tumor Death within Three Years after the Initial Operation

H. Tsuda, T. Hasebe, Y. Tsubono, 1997, Japanese journal of cancer research : Gann.

Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor.

H. Tsuda, Tsuyoshi Saito, Y. Toyama, 2012, Journal of proteomics.

Beta-catenin mutation in carcinoma of the uterine endometrium.

S. Hirohashi, H. Tsuda, M. Sakamoto, 1998, Cancer research.

Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.

S. Hirohashi, J. Yokota, H. Tsuda, 1988, Laboratory investigation; a journal of technical methods and pathology.

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis

H. Tsuda, H. Itoh, Y. Kamihara, 2001, Pathology international.

Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Y. Nakamura, S. Hirohashi, M. Emi, 1992, Cancer research.

Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma.

H. Hasegawa, S. Hirohashi, H. Tsuda, 1988, Gastroenterology.

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.

H. Asamura, H. Tsuda, K. Tsuta, 2013, Lung cancer.

Hamartoma of the parotid gland: A case report with immunohistochemical and electron microscopic study

T. Nakajima, H. Tsuda, Y. Shimosato, 2004, Virchows Archiv A.

Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma

H. Tsuda, M. Takano, K. Furuya, 2018, Pathology & Oncology Research.

FOXP1, an Estrogen-Inducible Transcription Factor, Modulates Cell Proliferation in Breast Cancer Cells and 5-Year Recurrence-Free Survival of Patients with Tamoxifen-Treated Breast Cancer

Akihiko Osaki, Hitoshi Tsuda, Satoshi Inoue, 2011, Hormones & cancer.

K. Horie-Inoue, S. Inoue, H. Tsuda, 2011, The Journal of Steroid Biochemistry and Molecular Biology.

PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma

J. Inazawa, H. Tsuda, I. Imoto, 2006, Cancer science.

PIK 3 CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma

J. Inazawa, H. Tsuda, I. Imoto, 2006 .

Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma

S. Miyano, Y. Totoki, F. Hosoda, 2014, Genome research.

PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma

H. Tsuda, M. Takano, O. Matsubara, 2011, The Journal of pathology.

Point Mutation of the E–Cadherin Gene in Invasive Lobular Carcinoma of the Breast

S. Hirohashi, T. Oda, H. Tsuda, 1994, Japanese journal of cancer research : Gann.

Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.

S. Hirohashi, J. Yokota, H. Tsuda, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis

H. Tsuda, Y. Kanai, A. Maeshima, 2013, Laboratory Investigation.

Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer.

M. Ando, M. Kodaira, M. Yunokawa, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression

H. Tsuda, 2009, Breast cancer.

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

H. Tsuda, M. Takano, O. Matsubara, 2012, Modern Pathology.

64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer

Yasuyoshi Watanabe, M. Kodaira, M. Yunokawa, 2013, The Journal of Nuclear Medicine.

Mutation Pattern of the p 53 Gene as a Diagnostic Marker for Multiple Hepatocellular Carcinoma 1

S. Hirohashi, T. Oda, A. Scarpa, 2006 .

Gene Mutation Spectrum in Hepatocellular Carcinoma 1

S. Hirohashi, T. Oda, A. Scarpa, 2006 .

p 53 Gene Mutation Spectrum in Hepatocellular Carcinoma 1

S. Hirohashi, T. Oda, A. Scarpa, 2006 .

Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c‐erbB‐2 expression patterns in both the non‐invasive and invasive portions

S. Hirohashi, H. Tsuda, Setsuo Hirohashi, 1998, Pathology international.

Bright-Field Dual-Color Chromogenic In Situ Hybridization for Diagnosing Echinoderm Microtubule-Associated Protein-Like 4-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinomas

T. Grogan, T. Kohno, T. Shibata, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Differential Prognostic Significance of Morphologic Invasive Markers in Colorectal Cancer: Tumor Budding and Cytoplasmic Podia

H. Ueno, J. Jass, H. Tsuda, 2006, Diseases of the colon and rectum.

ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.

H. Tsuda, H. Katai, T. Fujiwara, 2015, World journal of gastroenterology.

ARID 1 A expression in gastric adenocarcinoma : clinicopathological significance and correlation with DNA mismatch repair status MMR and ARID 1 A in gastric cancer

H. Tsuda, H. Katai, T. Fujiwara, 2015 .

Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens

T. Kohno, T. Shibata, T. Kinoshita, 2016, Carcinogenesis.

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2014, Gynecologic oncology.

p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer

H. Tsuda, T. Goto, M. Takano, 2009, International journal of cancer.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

S. Hirohashi, J. Inazawa, T. Kasamatsu, 2007, Cancer research.

Molecular Characterization of an Intact p53 Pathway Subtype in High-Grade Serous Ovarian Cancer

H. Tsuda, K. Yoshihara, T. Enomoto, 2014, PloS one.

Ectopic Hamartomatous Thymoma: A Review Of The Literature With Report Of New Cases And Proposal Of A New Name: Biphenotypic Branchioma

H. Tsuda, L. Thompson, T. Kono, 2017, Head and Neck Pathology.

Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity.

T. Kasamatsu, T. Ochiya, Masayuki Yoshida, 2016, Cancer research.

Anaplastic lymphoma kinase status in rhabdomyosarcomas

T. Shibata, H. Tsuda, M. Fukayama, 2013, Modern Pathology.

Utility of 10 Immunohistochemical Markers Including Novel Markers (Desmocollin-3, Glypican 3, S100A2, S100A7, and Sox-2) for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung

H. Asamura, H. Tsuda, K. Tsuta, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma

S. Imoto, J. Inazawa, R. Yamaguchi, 2016, Oncogene.

Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker.

Yukiko Nakamura, H. Asamura, H. Tsuda, 2012, Journal of proteomics.

ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis

Hiromi Nakamura, S. Kōzuma, Y. Taketani, 2009, The EMBO journal.

Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.

H. Tsuda, M. Igawa, O. Hino, 1997, The Journal of urology.

Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation

H. Tsuda, S. Fukushima, A. Maeshima, 2013, Brain Tumor Pathology.

Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas

S. Hirohashi, J. Inazawa, H. Tsuda, 2008, Clinical Cancer Research.

Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type

J. Inazawa, H. Tsuda, M. Takano, 2007, Modern Pathology.

Actinin-4, a Novel Actin-bundling Protein Associated with Cell Motility and Cancer Invasion

Hitoshi Tsuda, Ritsuko Endo, Setsuo Hirohashi, 1998, The Journal of cell biology.

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma

H. Tsuda, M. Takano, O. Matsubara, 2011, Virchows Archiv.

Association between frequent CpG island methylation and HER2 amplification in human breast cancers.

H. Tsuda, M. Kaminishi, T. Ushijima, 2009, Carcinogenesis.

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells

N. Kosaka, T. Ochiya, M. Ono, 2014, Science Signaling.

[Significance of RhoC expression in terms of invasion and metastasis of colorectal cancer].

H. Tsuda, O. Matsubara, E. Shinto, 2003, Nihon rinsho. Japanese journal of clinical medicine.

Detection of Alterations in Chromosomes 16 and 1 by Fluorescence in situ Hybridization in Breast Tumors Cytologically or Histologically Equivocal for Malignancy

S. Hirohashi, H. Tsuda, K. Shimamura, 1998, Pathobiology.

A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study

T. Ishikawa, T. Kinoshita, H. Tsuda, 2022, Cancer.

Primary epithelioid sarcoma of the vulva.

T. Kasamatsu, H. Tsuda, T. Hasegawa, 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Wide local extension and higher proliferation indices are characteristic features of symptomatic lobular neoplasias (LNs) and LNs with an early invasive component

T. Shibata, Masayuki Yoshida, T. Kinoshita, 2014, Histopathology.

Are Associated with Aggressive Inflammatory Breast Cancer Absence of Endothelial Cells , Central Necrosis , and Fibrosis Updated

T. Iwanaga, H. Tsuda, H. Wakasugi, 2001 .

Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer.

T. Iwanaga, H. Tsuda, K. Kato, 2001, Cancer research.

Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.

J. Inazawa, H. Tsuda, M. Ohki, 2001, Cancer research.

c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.

S. Hirohashi, T. Niki, H. Tsuda, 2001, The American journal of pathology.

Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours

Masayuki Yoshida, H. Tsuda, Y. Kanai, 2013, Histopathology.

Is florid pyloric metaplasia different from adenoma malignum?

T. Kasamatsu, H. Tsuda, S. Okada, 2000, Gynecologic oncology.

Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix.

H. Tsuda, T. Shimoda, I. Hayashi, 2000, The American journal of surgical pathology.

Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix

T. Kasamatsu, H. Tsuda, T. Shimoda, 2003, Virchows Archiv.

Lobular Endocervical Glandular Hyperplasia Is a Neoplastic Entity With Frequent Activating GNAS Mutations

T. Kasamatsu, Masayuki Yoshida, H. Tsuda, 2014, The American journal of surgical pathology.

Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and ‘adenoma malignum’ based on common histopathological criteria

T. Kasamatsu, H. Tsuda, F. Akiyama, 2005, Pathology international.

Invasive ductal carcinoma associated with tubular adenoma of the breast

H. Tsuda, H. Domoto, K. Miyakawa, 2002, Pathology international.

Efficacy of taxane regimens in patients with metastatic angiosarcoma.

K. Yonemori, Y. Fujiwara, H. Tsuda, 2011, European journal of dermatology : EJD.

Detection of amplified N-myc gene in neuroblastoma by in situ hybridization using the single-step silver enhancement method.

S. Hirohashi, M. Noguchi, T. Nakajima, 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

KIF5B-RET fusions in lung adenocarcinoma

Yasushi Totoki, Koji Tsuta, Shun-ichi Watanabe, 2012, Nature Medicine.

A proposal for the histopathological diagnosis of ductal carcinoma in situ of the Breast

H. Tsuda, F. Akiyama, M. Kurosumi, 2000, Breast cancer.

Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.

K. Horie-Inoue, S. Inoue, C. Shimizu, 2013, Clinical breast cancer.

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient

H. Tsuda, M. Takano, O. Matsubara, 2011, Modern Pathology.

Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance

Hitoshi Tsuda, Masashi Takano, Tesshi Yamada, 2009, Modern Pathology.

Laser microdissection and two-dimensional difference gel electrophoresis reveal proteomic intra-tumor heterogeneity in colorectal cancer.

H. Tsuda, T. Kondo, H. Taniguchi, 2013, Journal of proteomics.

Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.

Masahiko Miura, Hitoshi Tsuda, Setsuo Hirohashi, 2002, Cancer research.

Expression of cIAP 1 , a Target for 11 q 22 Amplification , Correlates with Resistance of Cervical Cancers to Radiotherapy 1

S. Hirohashi, J. Inazawa, H. Tsuda, 2002 .

Preoperative Differential Diagnosis of Minimal Deviation Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia of the Uterine Cervix: A Multicenter Study of Clinicopathology and Magnetic Resonance Imaging Findings

K. Togashi, H. Tsuda, T. Kaku, 2011, International Journal of Gynecologic Cancer.

Gross features of lobular endocervical glandular hyperplasia in comparison with minimal‐deviation adenocarcinoma and stage Ib endocervical‐type mucinous adenocarcinoma of the uterine cervix

T. Kasamatsu, H. Tsuda, T. Kaku, 2008, Histopathology.

Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2009, Pathology, research and practice.

Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix

T. Kasamatsu, H. Tsuda, F. Akiyama, 2003, Pathology international.

Serous Adenocarcinoma of the Uterine Cervix: A Clinicopathological Study of 12 Cases and a Review of the Literature

T. Kasamatsu, H. Tsuda, T. Onda, 2011, Gynecologic and Obstetric Investigation.

Breast carcinoma with osteoclast-like giant cells: a case report and review of the Japanese literature

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1999, Breast cancer.

der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis

S. Hirohashi, H. Tsuda, T. Fukutomi, 1999, Genes, chromosomes & cancer.

Apocrine carcinoma of the breast: Clinicopathological analysis and histological subclassification of 12 cases

H. Tsuda, Y. Kanai, S. Akashi-Tanaka, 1998, Breast cancer.

Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma

J. Inazawa, H. Tsuda, T. Asakage, 2021, Cancer science.

Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.

S. Hirohashi, T. Oda, H. Tsuda, 1995, Japanese journal of clinical oncology.

Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.

H. Tsuda, S. Aida, O. Matsubara, 2007, Human pathology.

Prevalence of pathogenic germline variants detected by multigene sequencing in unselected Japanese patients with ovarian cancer

H. Tsuda, K. Masuda, I. Imoto, 2017, Oncotarget.

Primary epithelioid sarcoma of the vulva

T. Kasamatsu, H. Tsuda, T. Hasegawa, 2001, International Journal of Gynecologic Cancer.

Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon Cancer

H. Ueno, H. Tsuda, K. Hase, 2020, Annals of Surgical Oncology.

Clinicopathological prognostic indicators in 107 patients with diffuse large B‐cell lymphoma transformed from follicular lymphoma

H. Tsuda, K. Tobinai, D. Maruyama, 2013, Cancer science.

Bcl‐2, Bcl‐6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

H. Tsuda, K. Tobinai, D. Maruyama, 2012, Cancer science.

Community‐acquired lobar pneumonia caused by Pseudomonas aeruginosa infection in Japan: A case report with histological and immunohistochemical examination

H. Tsuda, T. Sakamoto, O. Matsubara, 2014, Pathology international.

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

T. Shibata, M. Ono, K. Yonemori, 2012, Breast Cancer Research and Treatment.

Prognostic significance of the overexpression of c‐erbB‐2 protein in adenocarcinoma of the uterine cervix

S. Hirohashi, H. Tsuda, S. Tsugane, 1994, Cancer.

The Correlation Between Cytoplasmic Overexpression of Epidermal Growth Factor Receptor and Tumor Aggressiveness: Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma

Hidetaka Mochizuki, Hitoshi Tsuda, Shigeto Ueda, 2004, Pancreas.

BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non‐small cell lung cancer cell line

J. Inazawa, H. Tsuda, I. Imoto, 2007, Cancer science.

Overexpressed Skp2 within 5p amplification detected by array‐based comparative genomic hybridization is associated with poor prognosis of glioblastomas

T. Yoshimine, J. Inazawa, H. Tsuda, 2005, Cancer science.

Genetic Clustering of Clear Cell Renal Cell Carcinoma Based on Array-Comparative Genomic Hybridization: Its Association with DNA Methylation Alteration and Patient Outcome

S. Hirohashi, F. Hosoda, T. Shibata, 2008, Clinical Cancer Research.

Alterations in Copy Number of c‐erbB‐2 and c‐myc Proto‐oncogenes in Advanced Stage of Human Breast Cancer

S. Hirohashi, H. Tsuda, Y. Shimosato, 1991, Acta pathologica japonica.

Soft-tissue hemangioblastoma of the retroperitoneum: a case study and review of the literature.

H. Tsuda, M. Fukayama, J. Shibahara, 2010, Applied immunohistochemistry & molecular morphology : AIMM.

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis

H. Tsuda, O. Matsubara, J. Yamamoto, 2010, Breast Cancer Research and Treatment.

Combination of squamous cell carcinoma‐antigen, carcinoembryonic antigen, and carbohydrate antigen 19‐9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix

T. Kasamatsu, H. Tsuda, T. Onda, 2012, The journal of obstetrics and gynaecology research.

Serous component is a recurrence predictive factor of grade 1 endometrioid carcinoma at stage IA: A multi-institutional and retrospective study

H. Tsuda, M. Takano, T. Kita, 2019 .

Identification of PAK4 as a putative target gene for amplification within 19q13.12‐q13.2 in oral squamous‐cell carcinoma

J. Inazawa, H. Tsuda, I. Imoto, 2009, Cancer science.

Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis

H. Tsuda, M. Takano, K. Furuya, 2017, Journal of gynecologic oncology.

Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas

H. Tsuda, M. Takano, J. Hirata, 2017, Oncology.

Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma

H. Ueno, H. Tsuda, K. Tamura, 2013, International Journal of Clinical Oncology.

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix

T. Kasamatsu, H. Tsuda, T. Onda, 2009, British Journal of Cancer.

One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients

H. Tsuda, F. Akiyama, K. Tsugawa, 2007, Clinical Cancer Research.

Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2019, Virchows Archiv.

Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer

H. Tsuda, K. Oda, M. Shimada, 2022, Cancer science.

Histological and immunohistochemical analysis of apocrine breast carcinoma

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2002, Breast cancer.

SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation

J. Inazawa, H. Tsuda, I. Imoto, 2012, Oncogene.

ROS1-Rearranged Lung Cancer: A Clinicopathologic and Molecular Study of 15 Surgical Cases

T. Kohno, T. Shibata, H. Asamura, 2013, The American journal of surgical pathology.

Mouse Model for ROS1-Rearranged Lung Cancer

Y. Totoki, T. Kohno, F. Hosoda, 2013, PloS one.

Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma

T. Shibata, H. Asamura, H. Tsuda, 2013, Journal of Clinical Pathology.

Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays

H. Ueno, J. Inazawa, H. Tsuda, 2005, Laboratory Investigation.

The subserosal elastic lamina: An anatomic landmark for stratifying pT3 colorectal cancer

H. Ueno, H. Tsuda, O. Matsubara, 2004, Diseases of the colon and rectum.

Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers

M. Ono, M. Yunokawa, K. Yonemori, 2015, Breast Cancer.

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

N. Kanomata, C. Shimizu, H. Tsuda, 2014, Breast Cancer.

Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis.

C. Shimizu, T. Kinoshita, Y. Fujiwara, 2011, Japanese journal of clinical oncology.

Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features

Hitoshi Tsuda, Kakuya Kitagawa, Akinori Ishihara, 2009, Breast cancer.

Individualization of breast cancer based on histopathological features and molecular alterations

H. Tsuda, 2008, Breast cancer.

Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma

H. Tsuda, M. Takano, M. Miyamoto, 2022, Cancer medicine.

On-tissue polysulfide visualization by surface-enhanced Raman spectroscopy benefits patients with ovarian cancer to predict post-operative chemosensitivity

K. Iwaisako, T. Kasamatsu, M. Suematsu, 2021, Redox biology.

A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.

T. Kasamatsu, H. Tsuda, K. Ariyoshi, 2019, Gynecologic oncology.

Significant relationship between the LAT1 expression pattern and chemoresistance in ovarian clear cell carcinoma

H. Tsuda, M. Takano, K. Furuya, 2019, Virchows Archiv.

Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group.

Yosuke Konno, Masayuki Yoshida, H. Tsuda, 2022, Human pathology.

The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.

Kenji Suzuki, J. Yokota, T. Kohno, 2011, Lung cancer.

Vascular endothelial growth factor mRNA levels quantified by reverse transcription–polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components

H. Tsuda, O. Matsubara, N. Imazeki, 2005, Pathology international.

Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease

H. Tsuda, N. Yamazaki, R. Tanaka, 2013, The British journal of dermatology.

Solitary esophageal metastasis of breast cancer with 15 years' latency: A case report and review of the literature

Y. Tachimori, H. Tsuda, Y. Nakanishi, 1997, Pathology international.

Laser microdissection and two-dimensional difference gel electrophoresis with alkaline isoelectric point immobiline gel reveals proteomic intra-tumor heterogeneity in colorectal cancer

H. Tsuda, T. Kondo, Y. Murakami, 2013 .

Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2015, Oncotarget.

Anal canal neuroendocrine carcinoma associated with squamous intraepithelial neoplasia: A human papillomavirus 18‐related lesion

H. Tsuda, H. Taniguchi, Y. Moriya, 2012, Pathology international.

Prognostic Value of p53 Protein Accumulation in Cancer Cell Nuclei in Adenocarcinoma of the Uterine Cervix

S. Hirohashi, H. Tsuda, S. Tsugane, 1995, Japanese journal of cancer research : Gann.

Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver

H. Tsuda, D. Morita, O. Matsubara, 2006, Pathology international.

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2013, British Journal of Cancer.

Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2012, Cancer science.

Immunohistochemical Profile for Unknown Primary Adenocarcinoma

Yasuhiro Fujiwara, Akihiro Hirakawa, Hitoshi Tsuda, 2012, PloS one.

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Tatsuhiko Tsunoda, Hiroyuki Seki, Daichi Shigemizu, 2012, Clinical Cancer Research.

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

Kenichi Inoue, Hitoshi Tsuda, Hiroyuki Takei, 2007, Breast Cancer Research and Treatment.

Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas

H. Tsuda, M. Takano, O. Matsubara, 2012, Modern Pathology.

Cholangiocarcinomas in japanese and thai patients: Difference in etiology and incidence of point mutation of the c‐KI‐ras proto‐oncogene

S. Hirohashi, H. Tsuda, T. Sugimura, 1992, Molecular carcinogenesis.

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study

H. Tsuda, S. Masuda, M. Kurosumi, 2013, Cancer science.

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

H. Tsuda, F. Akiyama, M. Kurosumi, 2008, Journal of Cancer Research and Clinical Oncology.

Pattern of Chromosome 16q Loss Differs between an Atypical Proliferative Lesion and an Intraductal or Invasive Ductal Carcinoma Occurring Subsequently in the Same Area of the Breast

S. Hirohashi, H. Tsuda, S. Akashi-Tanaka, 2001, Modern Pathology.

Correlation of numerical and structural status of chromosome 16 with histological type and grade of non‐invasive and invasive breast carcinomas

S. Hirohashi, H. Tsuda, Setsuo Hirohashi, 1999, International journal of cancer.

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

K. Yonemori, C. Shimizu, T. Kinoshita, 2010, British Journal of Cancer.

NKX2.2 is a Useful Immunohistochemical Marker for Ewing Sarcoma

H. Tsuda, M. Fukayama, K. Tsuta, 2012, The American journal of surgical pathology.

Important Histologic Outcome Predictors for Patients With Invasive Ductal Carcinoma of the Breast

T. Shibata, T. Kinoshita, H. Tsuda, 2011, The American journal of surgical pathology.

Atypical Tumor-stromal Fibroblasts in Invasive Ductal Carcinoma of the Breast

T. Shibata, T. Kinoshita, H. Tsuda, 2011, American Journal of Surgical Pathology.

p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast

T. Shibata, T. Kinoshita, H. Tsuda, 2010, Modern Pathology.

Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness

S. Hirohashi, H. Tsuda, Y. Shimosato, 1996, Japanese journal of cancer research : Gann.

Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.

H. Tsuda, T. Goto, M. Takano, 2016, Molecular and clinical oncology.

Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer.

S. Hirohashi, H. Tsuda, S. Tsugane, 1997, Japanese journal of clinical oncology.

What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard.

H. Tsuda, F. Akiyama, M. Kurosumi, 2008, American Journal of Clinical Pathology.

Frequent activating GNAS mutations in villous adenoma of the colorectum

H. Tsuda, Y. Kanai, M. Yamada, 2012, The Journal of pathology.

Histological differences between invasive ductal carcinoma with a large central acellular zone and matrix‐producing carcinoma of the breast

H. Tsuda, O. Matsubara, S. Ueda, 2009, Pathology international.

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones.

S. Hirohashi, H. Tsuda, T. Hasegawa, 1999, Human pathology.

p40 is the Best Marker for Diagnosing Pulmonary Squamous Cell Carcinoma: Comparison With p63, Cytokeratin 5/6, Desmocollin-3, and Sox2

Kenji Suzuki, H. Tsuda, K. Tsuta, 2014, Applied immunohistochemistry & molecular morphology : AIMM.

Prognostic Model of Stage II/III Colon Cancer Constructed using Gene Expression Subtypes and KRAS Mutation Status

H. Ueno, H. Tsuda, Kengo Gotoh, 2018 .

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

H. Tsuda, M. Kurosumi, R. Osamura, 2010, BMC Cancer.

Clinicopathological characteristics of triple-negative breast cancers

H. Tsuda, Yuka Sasaki, 2009, Breast cancer.

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

C. Shimizu, Y. Fujiwara, H. Tsuda, 2009, Japanese journal of clinical oncology.

A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections

Brian D. Kelly, T. Grogan, H. Tsuda, 2012, Diagnostic Pathology.

p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade

S. Hirohashi, H. Tsuda, T. Fukutomi, 1993, Japanese journal of cancer research : Gann.

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

Masayuki Yoshida, M. Yunokawa, K. Yonemori, 2017, Cancer science.

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

S. Hirohashi, H. Tsuda, T. Fukutomi, 1991, Japanese journal of cancer research : Gann.

Nucleostemin expression in invasive breast cancer

Y. Fujiwara, H. Tsuda, K. Tamura, 2014, BMC Cancer.

Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature

H. Tsuda, M. Takano, M. Miyamoto, 2021, Journal of Ovarian Research.

Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.

S. Hirohashi, H. Tsuda, S. Tsugane, 1998, Japanese journal of clinical oncology.

Overexpression of c‐erbB‐2 protein in gastric cancer. Its correlation with long‐term survival of patients

S. Hirohashi, H. Tsuda, M. Sasako, 1993 .

Ovarian cancer therapeutic potential of glutamine depletion based on GS expression

Y. Song, J. Inazawa, N. Miyasaka, 2018, Carcinogenesis.

HER-2 (c-erbB-2) test update: Present status and problems

H. Tsuda, 2006, Breast cancer.

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, British Journal of Cancer.

Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers

H. Tsuda, K. Wakazono, Y. Yagi, 2003, Oncology.

A new reporting form for breast cytology

H. Tsuda, F. Akiyama, H. Itoh, 2009, Breast cancer.

Combined high‐grade neuroendocrine carcinoma of the lung: Clinicopathological and immunohistochemical study of 34 surgically resected cases

H. Tsuda, K. Tsuta, A. Maeshima, 2014, Pathology international.

Reduced p21WAF1/CIP1 expression and p53 mutation in hepatocellular carcinomas

S. Hirohashi, H. Tsuda, Y. Kanai, 1997, Hepatology.

A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study

H. Tsuda, M. Kurosumi, Toru Watanabe, 2000, Pathology international.

Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

H. Tsuda, D. Aoki, N. Susumu, 2004, International Journal of Gynecologic Cancer.

J. Inazawa, H. Tsuda, D. Aoki, 2004, International Journal of Gynecologic Cancer.

Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy.

S. Kosuda, H. Tsuda, S. Kusano, 2004, American journal of surgery.

A CASE OF METASTASES OF THE LUNG AND ADRENAL GLAND FROM MALIGNANT PHYLLODES TUMOR SUCCESSFULLY TREATED BY IFOSFAMIDE

H. Tsuda, H. Mochizuki, Kazuhiko Sato, 2003 .

A case of malignant phyllodes tumor of the Breast with osteosarcomatous features

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1999, Breast Cancer.

Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306

H. Iwata, H. Tsuda, H. Mukai, 2013, Oncology.

Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin.

S. Hirohashi, T. Oda, H. Tsuda, 1992, Cancer research.

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2008, Cancer letters.

Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicin

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2001, Breast Cancer.

Squamous cell carcinoma of the breast in the form of an intracystic tumor

H. Tsuda, S. Ueda, H. Mochizuki, 2007, Breast cancer.

Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.

S. Hirohashi, H. Tsuda, T. Fukutomi, 1997, Japanese journal of clinical oncology.

A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases

S. Hirohashi, H. Tsuda, S. Tsugane, 1998, Breast Cancer Research and Treatment.

beta‐2‐microglobulin expression in relation to amplification of oncogenes and prognosis in breast carcinoma

S. Hirohashi, H. Tsuda, Y. Shimosato, 1990, Histopathology.

Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)

H. Tsuda, H. Mukai, F. Akiyama, 2008, Breast cancer.

Recent advances in sentinel node biopsy for breast cancer Histological examination of sentinel lymph nodes : significance of macrometastasis , micrometastasis , and isolated tumor cells

H. Tsuda, 2015 .

Routine clinical use of the one‐step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients

T. Kinoshita, H. Tsuda, F. Akiyama, 2012, Cancer.

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study

H. Tsuda, K. Yoshihara, T. Enomoto, 2020, Cancer science.

Histopathological criteria for assessment of therapeutic response in breast cancer

H. Tsuda, F. Akiyama, M. Kurosumi, 2001, Breast cancer.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, Carcinogenesis.

Pilomyxoid astrocytoma of the fourth ventricle in an adult

H. Tsuda, H. Nawashiro, K. Shima, 2008, Acta Neurochirurgica.

Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer

H. Shinmoto, H. Tsuda, K. Nakanishi, 2019, Modern Pathology.

Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma.

H. Tsuda, M. Takano, K. Furuya, 2017, Molecular and clinical oncology.

Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer.

H. Tsuda, F. Akiyama, M. Kurosumi, 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A case of unclassified high‐grade glioma with polar spongioblastoma pattern

A. Shinomiya, H. Tsuda, S. Fukushima, 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

Optimal particle size of radiocolloid for sentinel node identification in breast cancer — Electron microscopic study and clinical comparison

S. Kosuda, D. Krag, H. Tsuda, 2004, Breast cancer.

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

A. Shimomura, K. Yonemori, T. Kinoshita, 2020, Breast Cancer Research and Treatment.

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

T. Shibata, C. Shimizu, T. Kinoshita, 2011, Human pathology.

TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model

H. Tsuda, T. Maekawa, F. Kimura, 2018, International Journal of Hematology.

Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer

C. Shimizu, T. Kinoshita, Y. Fujiwara, 2013, Breast Cancer.

Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma.

H. Tsuda, S. Todo, O. Matsubara, 2012, Experimental and therapeutic medicine.

Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid‐tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation

J. Inazawa, H. Tsuda, D. Morita, 2005, Cancer Science.

Detection of HER‐2/neu (c‐erb B‐2) DNA amplification in primary breast carcinoma

H. Tsuda, F. Akiyama, M. Kurosumi, 2001, Cancer.

Uptake and kinetics of 5-aminolevulinic acid in oral squamous cell carcinoma.

H. Tsuda, H. Harada, K. Omura, 2010, International journal of oral and maxillofacial surgery.

Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma

Masayuki Yoshida, H. Tsuda, O. Ishihara, 2019, Journal of Ovarian Research.

Combined measurement of the c‐erbb‐2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse

H. Tsuda, T. Fukutomi, K. Sugano, 2000, International journal of cancer.

A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): therapeutic efficacy and clinical implications of circulating endothelial cells

H. Tsuda, F. Akiyama, M. Kurosumi, 2018, Cancer medicine.

Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer

H. Ueno, H. Tsuda, J. Yamamoto, 2020, Oncology letters.

Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer

H. Ueno, H. Tsuda, K. Hase, 2019, Virchows Archiv.

Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study

H. Miyata, Masayuki Yoshida, T. Kinoshita, 2020, Breast Cancer Research and Treatment.

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin

H. Tsuda, M. Takano, K. Furuya, 2017, Medical Oncology.

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.

T. Kinoshita, Y. Fujiwara, H. Tsuda, 2012, Breast.

Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma

H. Tsuda, I. Oda, H. Katai, 2014, Virchows Archiv.

Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy.

T. Kinoshita, H. Tsuda, T. Hojo, 2013, Clinical breast cancer.

Evaluation of interobserver agreement in scoring immunohistochemical results of HER‐2/neu (c‐erbB‐2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma

H. Tsuda, F. Akiyama, M. Kurosumi, 2002, Pathology international.

Concordance in judgments among c‐erbB‐2 (HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma

H. Tsuda, T. Fukutomi, T. Hasegawa, 2001, Pathology international.

Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease

H. Tsuda, Y. Fujisawa, M. Fujimoto, 2016, Clinical & Experimental Metastasis.

correlation between histologic grade of malignancy and copy number of c‐erbb‐2 gene in breast carcinoma. A retrospective analysis of 176 cases

S. Hirohashi, H. Tsuda, Y. Shimosato, 1990, Cancer.

Bilateral nonpalpable breast carcinomas in a patient withbrca2 germ line mutation and past history of osteosarcoma

Y. Miki, H. Tsuda, Y. Kanai, 1999, Breast cancer.

New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay

Brian D. Kelly, T. Grogan, H. Tsuda, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis

G. Ball, A. Green, E. Rakha, 2021, Breast Cancer Research and Treatment.

Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab)

H. Tsuda, F. Akiyama, M. Kurosumi, 2001, Breast cancer.

A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

H. Tsuda, O. Matsubara, J. Yamamoto, 2013, BMC Clinical Pathology.

Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan

H. Miyata, H. Tsuda, K. Tamura, 2021, Breast Cancer.

Comparative study of the value of dual tracer PET/CT in evaluating breast cancer

T. Kinoshita, H. Tsuda, U. Tateishi, 2012, Cancer science.

Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma

T. Kasamatsu, H. Tsuda, T. Onda, 2012, Cancer science.

Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Anticancer research.

Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis.

H. Asamura, H. Tsuda, K. Tsuta, 2011, Annals of diagnostic pathology.

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

J. Inazawa, H. Tsuda, I. Imoto, 2014, British Journal of Cancer.

Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure.

S. Kosuda, H. Tsuda, S. Kusano, 2001, Japanese journal of clinical oncology.

Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.

H. Tsuda, F. Akiyama, M. Kurosumi, 1999, Japanese journal of clinical oncology.

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer

J. Inazawa, H. Tsuda, M. Takano, 2014, Acta histochemica et cytochemica.

Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer

H. Ueno, H. Tsuda, T. Einama, 2019, BMC Cancer.

Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast

T. Shibata, T. Kinoshita, H. Tsuda, 2013, Cancer science.

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

T. Shibata, T. Kinoshita, H. Tsuda, 2011, Human pathology.

Radiofrequency ablation as local therapy for early breast carcinomas

T. Kinoshita, H. Tsuda, E. Iwamoto, 2011, Breast cancer.

Radiofrequency ablation therapy for primary breast cancer: expectations and problems as a novel breast conservation therapy

H. Tsuda, 2011, Breast cancer.

Prognostic and predictive value of c-erbB-2 (HER-2/neu) gene amplification in human Breast Cancer

H. Tsuda, 2001 .

Histological Factors Associated with Initial Bone Metastasis of Invasive Ductal Carcinoma of the Breast

S. Hirohashi, H. Tsuda, T. Hasebe, 1999, Japanese journal of cancer research : Gann.

The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

H. Tsuda, F. Akiyama, M. Kurosumi, 1999, Japanese journal of clinical oncology.

Prognostic Significance of Progesterone Receptor Expression in Estrogen‐Receptor Positive, HER2‐Negative, Node‐Negative Invasive Breast Cancer With a Low Ki‐67 Labeling Index

M. Ono, Masayuki Yoshida, C. Shimizu, 2017, Clinical breast cancer.

Improving Interobserver Agreement When Judging Nuclear Atypia of Breast Cancer

H. Tsuda, F. Akiyama, M. Kurosumi, 2010 .

Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40–44 years

Masayuki Yoshida, C. Shimizu, T. Kinoshita, 2018, Breast Cancer.

Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer

H. Tsuda, F. Akiyama, M. Kurosumi, 2006, Breast cancer.

The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody.

H. Tsuda, Tsuyoshi Saito, T. Kondo, 2013, Japanese journal of clinical oncology.

Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.

H. Tsuda, Tsuyoshi Saito, T. Kondo, 2012, Japanese journal of clinical oncology.

Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatment.

T. Kinoshita, H. Tsuda, Y. Seto, 2015, Japanese journal of clinical oncology.

ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation

S. Hirohashi, F. Hosoda, J. Inazawa, 2005, Oncogene.

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer

H. Tsuda, E. Otsuji, A. Shiozaki, 2021, Journal of Cancer.

Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgery

T. Kinoshita, H. Tsuda, T. Hojo, 2014, Breast Cancer.

Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors

H. Tsuda, M. Takano, M. Miyamoto, 2020, In Vivo.

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

H. Tsuda, M. Takano, K. Furuya, 2018, In vivo.

Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.

H. Iwata, H. Tsuda, F. Akiyama, 2011, Japanese journal of clinical oncology.

Tumor Buds Show Reduced Expression of Laminin-5 Gamma 2 Chain in DNA Mismatch Repair Deficient Colorectal Cancer

H. Ueno, W. Foulkes, J. Jass, 2006, Diseases of the colon and rectum.

Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma

Masaru Ushijima, Yoshio Miki, Hitoshi Tsuda, 2007, Cancer science.

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

H. Iwata, H. Tsuda, F. Akiyama, 2005, Breast cancer.

Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2002, Breast cancer.

Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer

C. Desmedt, D. Larsimont, P. V. van Diest, 2022, Modern Pathology.

Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.

T. Shien, H. Iwata, Masayuki Yoshida, 2021, Japanese journal of clinical oncology.

Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

S. Hirohashi, J. Inazawa, H. Tsuda, 1997, The American journal of pathology.

Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2002, Breast cancer.

Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma

C. Shimizu, H. Tsuda, S. Akashi-Tanaka, 2001, Journal of surgical oncology.

Clinicopathologic and prognostic features of triple-negative breast cancer analyzed in registration data of the Japanese Breast Cancer Society, 11705 cases.

H. Tsuda, M. Kurosumi, K. Miyamoto, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.

H. Iwata, H. Tsuda, Y. Ohashi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interpretation of HER2 tests in gastric cancer: confirmation of interobserver differences and validation of a QA/QC educational program

H. Tsuda, S. Masuda, A. Ochiai, 2014, Virchows Archiv.

A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy

H. Tsuda, K. Ichimura, S. Fukushima, 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

Prognostic value of histopathological therapeutic effects and mitotic index in locally advanced breast cancers after neoadjuvant chemotherapy.

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 1996, Japanese journal of clinical oncology.

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

H. Tsuda, I. Nagaoka, T. Goto, 2018, Oncology letters.

Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

H. Tsuda, F. Akiyama, M. Kurosumi, 1998, Japanese journal of clinical oncology.

High-level Skp2 Expression in Pancreatic Ductal Adenocarcinoma: Correlation with the Extent of Lymph Node Metastasis, Higher Histological Grade, and Poorer Patient Outcome

H. Tsuda, D. Morita, O. Matsubara, 2006, Pancreas.

Grade 1 Endometrioid Carcinoma With an Area of Serous Carcinoma Less than 5% Is More Aggressive than Stage IA Pure-type Grade 1 Endometrioid Carcinoma

H. Tsuda, M. Takano, T. Kita, 2021, In Vivo.

Zone Formation of Lymphocyte Infiltration at the Invasive Front Results in the Prolonged Survival of Individuals With Endometrial Serous Carcinoma and Endometrioid Carcinoma With Serous Component

H. Tsuda, M. Takano, K. Furuya, 2019, AntiCancer Research.

Oncogenic Ras/ERK Signaling Activates CDCP1 to Promote Tumor Invasion and Metastasis

J. Yokota, R. Sakai, H. Tsuda, 2014, Molecular Cancer Research.

Oncogenes and Tumor Suppressors Oncogenic Ras / ERK Signaling Activates CDCP 1 to Promote Tumor Invasion and Metastasis

J. Yokota, R. Sakai, H. Tsuda, 2014 .

Low-grade serous ovarian carcinoma is a rare histological subtype in Japan

H. Tsuda, M. Takano, M. Miyamoto, 2020 .

Histopathological assessment of anastrozole versus tamoxifen as preoperative treatment in postmenopausal women with T2-4b, N0-2, M0 breast cancer: Results from a randomized, double-blind study

H. Tsuda, F. Akiyama, S. Noguchi, 2005 .

Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2015, Breast Cancer.

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

A. Shimomura, H. Tsuda, F. Akiyama, 2020, Breast Cancer Research and Treatment.

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer

T. Shibata, J. Inazawa, T. Kinoshita, 2019, BMC Cancer.

The Haphazard Pattern in Grade-3 Endometrioid Carcinoma Is Associated with Poor Prognosis and Tumor Lymphocyte Infiltration

H. Tsuda, M. Takano, K. Furuya, 2019, Pathology & Oncology Research.

ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array‐based comparative genomic hybridization

J. Inazawa, H. Tsuda, I. Imoto, 2008, Cancer science.

Abstract CT137: Phase II study of trastuzumab and docetaxel therapy in patients with HER2-positive recurrent and/or metastatic salivary gland carcinoma

H. Tsuda, Y. Matsuno, H. Dosaka-akita, 2019, Clinical Trials.

Abstract P2-11-11: Role of postmastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer patients: A study from the Japanese breast cancer registry

H. Miyata, T. Kinoshita, H. Tsuda, 2018 .

p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer.

N. Taira, T. Shien, H. Doihara, 2013, Acta medica Okayama.

Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response

N. Fujiuchi, H. Matsuda, E. Imabayashi, 2012 .

Accuracy of contrast‐enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2001, International journal of cancer.

Diagnostic value of contrast-enhanced computed tomography for diagnosing the intraductal component of breast cancer

Kunihisa Miyakawa, Nachiko Uchiyama, Hitoshi Tsuda, 1998, Breast Cancer Research and Treatment.

Contrast-enhanced computed tomography for diagnosing the intraductal component and small invasive foci of Breast Cancer

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2001, Breast cancer.

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

T. Grogan, M. Okada, H. Asamura, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.

J. Inazawa, H. Tsuda, M. Takano, 2015, The American journal of pathology.

Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis

T. Ishikawa, T. Kinoshita, H. Tsuda, 2018, Annals of Surgical Oncology.

Evaluation of histopathological criteria for identifying nodenegative breast cancer witn high risk of early recurrence in the nsas-bc protocol study

H. Tsuda, S. Akashi-Tanaka, T. Fukutomi, 2000, Breast cancer.

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements

Hidetaka Mochizuki, Hitoshi Tsuda, Tadaaki Maehara, 2004, Virchows Archiv.

311 Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients

T. Kinoshita, H. Tsuda, T. Hasebe, 2010 .

Feasibility of breast conserving surgery for Paget's disease.

T. Kinoshita, H. Tsuda, S. Akashi-Tanaka, 2011, Breast.

Gene Expression Network Analysis of ETV1 Reveals KCTD10 as a Novel Prognostic Biomarker in Gastrointestinal Stromal Tumor

H. Tsuda, Tsuyoshi Saito, T. Kondo, 2013, PloS one.

Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma

A. Gemma, M. Ono, Masayuki Yoshida, 2020, British Journal of Cancer.

Expression of a splicing variant of the CADM1 specific to small cell lung cancer

H. Tsuda, Y. Kanai, Y. Murakami, 2012, Cancer science.

Breast cancer in Cowden's disease: a case report with review of the literature.

H. Tsuda, Y. Kanai, S. Akashi-Tanaka, 1998, Japanese journal of clinical oncology.

Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society

T. Shien, H. Tsuda, K. Tsugawa, 2017, Breast Cancer.

Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2016, Breast Cancer.

Reproducible Immunohistochemical Criteria Based on Multiple Raters’ Judgments for Expression of Thymidine Phosphorylase in Breast Cancer Tissue

H. Tsuda, F. Akiyama, M. Kurosumi, 2004, Breast Cancer Research and Treatment.

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

H. Iwata, Y. Fujiwara, H. Tsuda, 2012, Clinical breast cancer.

A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer

T. Shibata, T. Kinoshita, H. Tsuda, 2011, Breast Cancer.

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

H. Tsuda, M. Kurosumi, Tsuyoshi Saito, 2006 .

Validation of the Histologic Grading for Ovarian Clear Cell Adenocarcinoma: A Retrospective Multi-institutional Study by the Japan Clear Cell Carcinoma Study Group

H. Tsuda, J. Kigawa, N. Yaegashi, 2011, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors

H. Tsuda, M. Takano, O. Matsubara, 2008, Modern Pathology.

Proteomic analysis in usual and nonspecific interstitial pneumonia.

H. Tsuda, K. Nakanishi, S. Aida, 2014, Histology and histopathology.

Insulin-dependent diabetic mastopathy : A case report

H. Tsuda, Y. Kanai, S. Akashi-Tanaka, 1997, Breast cancer.

Correlation of high LAT1 expression with the prognosis of endometrioid carcinoma of the uterine corpus

H. Tsuda, M. Takano, M. Miyamoto, 2020, Virchows Archiv.

Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

H. Iwata, H. Tsuda, H. Mukai, 2020, Breast Cancer.

Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, American journal of cancer research.

A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes

H. Tsuda, M. Takano, M. Miyamoto, 2021, Anticancer Research.

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer

T. Shibata, J. Inazawa, T. Kinoshita, 2019, BMC Cancer.

Cathepsin D as a potential prognostic marker for lung adenocarcinoma.

M. Okada, H. Asamura, H. Tsuda, 2012, Pathology, research and practice.

Frequent occurrence of c-Ki-ras gene mutations in well differentiated endometrial adenocarcinoma showing infiltrative local growth with fibrosing stromal response.

S. Hirohashi, H. Tsuda, T. Yamada, 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2016, Clinical breast cancer.

The expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer

A. Shiotani, H. Tsuda, I. Imoto, 2014, Human Cell.

Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.

S. Hirohashi, H. Tsuda, T. Fukutomi, 1997, British Journal of Cancer.

Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival

H. Iwata, H. Tsuda, F. Akiyama, 2008, Breast Cancer Research and Treatment.

Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice.

H. Tsuda, K. Nakagawa, Y. Endo, 2000, Anti-cancer drug design.

Peritoneal Washing Cytology in Small Cell Carcinoma of the Uterine Cervix. A case report.:A case report

H. Tsuda, Y. Uei, Takuro Yamada, 1993 .

Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities.

H. Tsuda, T. Kondo, H. Katai, 2011, Japanese journal of clinical oncology.

MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma

H. Tsuda, M. Takano, M. Miyamoto, 2021, Virchows Archiv.

FOXP1 as a Potential ER Coregulator in Human Breast Cancer.

S. Inoue, H. Tsuda, K. Ikeda, 2009 .

Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancer.

H. Ueno, H. Tsuda, J. Yamamoto, 2015, Japanese journal of clinical oncology.

Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status

H. Asamura, H. Tsuda, K. Tsuta, 2012, Cancer.

BCL 2 L 2 is a probable target for novel 14 q 11 . 2 amplification detected in a non-small cell lung cancer cell line

J. Inazawa, H. Tsuda, I. Imoto, 2007 .

Overexpression of c‐erbB‐2 protein in gastric cancer. Its correlation with long‐term survival of patients

S. Hirohashi, H. Tsuda, M. Sasako, 1993, Cancer.

Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung.

Kenji Suzuki, M. Kusumoto, H. Asamura, 2014, The Annals of thoracic surgery.

Aquaporin 3 Expression in Endometrioid Carcinoma of the Uterine Body Correlated With Early Stage and Lower Grade

H. Tsuda, M. Takano, Takanori Watanabe, 2020, Pathology & Oncology Research.

Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation

Masayuki Yoshida, H. Tsuda, Y. Kanai, 2010, British Journal of Cancer.

Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas.

T. Grogan, H. Asamura, H. Tsuda, 2013, Human pathology.

Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma.

Kenji Suzuki, H. Asamura, H. Tsuda, 2014, Pathology, research and practice.

Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma

H. Tsuda, K. Ito, K. Honda, 2023, Cancer science.

[Molecular mechanisms of breast cancer progression].

H. Tsuda, 1996, Nihon Geka Gakkai zasshi.

Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.

T. Grogan, M. Okada, H. Asamura, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Different Prognostic Implications of Aquaporin-1 and Aquaporin-5 Expression among Different Histological Types of Ovarian Carcinoma

H. Tsuda, M. Takano, K. Furuya, 2018, Pathology & Oncology Research.

High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.

J. Inazawa, H. Tsuda, M. Takano, 2015, The American journal of pathology.

Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.

H. Iwata, H. Tsuda, F. Akiyama, 2011, Japanese journal of clinical oncology.

c-MET/Phospho-MET Protein Expression and MET Gene Copy Number in Non-small Cell Lung Carcinomas

T. Kohno, H. Asamura, H. Tsuda, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.

H. Tsuda, N. Susumu, K. Takehara, 2020, Gynecologic oncology.

Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma

H. Tsuda, M. Ikegami, H. Taniguchi, 2013, Pathology international.

Recent advances in sentinel node biopsy for breast cancer Histological examination of sentinel lymph nodes : significance of macrometastasis , micrometastasis , and isolated tumor cells

H. Tsuda, 2015 .

Histopathological Evaluation of the Therapeutic Effect of RFA for Early Breast Cancer

Masayuki Yoshida, T. Kinoshita, H. Tsuda, 2016 .

Final analysis of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment (NST) in early breast cancer (EBC): Japan Clinical Oncology Group Trial (JCOG0306).

H. Tsuda, H. Mukai, A. Sato, 2010 .

Histopathological effect of radiofrequency ablation therapy for primary breast cancer, with special reference to changes in cancer cells and stromal structure and a comparison with enzyme histochemistry

T. Kinoshita, H. Tsuda, E. Iwamoto, 2011, Breast cancer.

Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis

H. Ueno, H. Tsuda, Y. Kajiwara, 2020, Oncotarget.

Follow-up Data of 10 Patients With B-cell Non-Hodgkin Lymphoma With a CD20-negative Phenotypic Change After Rituximab-containing Therapy

H. Tsuda, K. Tobinai, D. Maruyama, 2013, The American journal of surgical pathology.

Non-small cell lung cancer, early stage

L. Bubendorf, T. Yamanaka, M. Okada, 2012 .

ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array‐based comparative genomic hybridization

J. Inazawa, H. Tsuda, I. Imoto, 2008, Cancer Science.

Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatment.

T. Kinoshita, H. Tsuda, Y. Seto, 2015, Japanese journal of clinical oncology.

Comparison between AJCC 8th prognostic stage and UICC anatomical stage in patients with primary breast cancer: a single institutional retrospective study

H. Ueno, H. Tsuda, Y. Kishi, 2020, Breast Cancer.

Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator

H. Asamura, H. Tsuda, K. Tsuta, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

H. Tsuda, F. Akiyama, M. Kurosumi, 2007, International journal of oncology.

Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma

T. Shibata, H. Asamura, H. Tsuda, 2013, Journal of Clinical Pathology.

Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung.

Kenji Suzuki, M. Kusumoto, H. Asamura, 2014, The Annals of thoracic surgery.

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix

T. Kasamatsu, H. Tsuda, T. Onda, 2009, British Journal of Cancer.